Verrica Pharmaceuticals Inc.
VRCA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $40,902 | $50,287 | $41,918 | $47,128 |
| - Cash | $21,097 | $15,396 | $29,595 | $46,329 |
| + Debt | $14,118 | $38,892 | $42,433 | $45,939 |
| Enterprise Value | $33,923 | $73,783 | $54,756 | $46,738 |
| Revenue | $14,344 | $12,702 | $3,439 | $344 |
| % Growth | 12.9% | 269.4% | 899.7% | – |
| Gross Profit | $13,235 | $12,362 | $3,016 | -$281 |
| % Margin | 92.3% | 97.3% | 87.7% | -81.7% |
| EBITDA | $2,004 | $2,534 | -$7,331 | -$13,600 |
| % Margin | 14% | 19.9% | -213.2% | -3,953.5% |
| Net Income | -$274 | $204 | -$9,742 | -$16,202 |
| % Margin | -1.9% | 1.6% | -283.3% | -4,709.9% |
| EPS Diluted | -0.03 | 0.022 | -1.03 | -2.41 |
| % Growth | -239.5% | 102.1% | 57.3% | – |
| Operating Cash Flow | $9,685 | -$10,044 | -$12,677 | -$16,064 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $9,685 | -$10,044 | -$12,677 | -$16,064 |